Article Details
Retrieved on: 2022-02-11 17:11:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer (PFE), AstraZeneca (AZN) and Glaxo (GSK) report fourth-quarter results. FDA approves Sanofi's (SNY) new rare blood disorder drug.
Article found on: www.entrepreneur.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here